Answers are grounded in this paper and cite their sources.
Diabetes Insipidus (DI) is rare, with an estimated incidence of 1 in 25,000 cases; less than 10% of cases are hereditary. CDI accounts for over 90% of DI cases and can appear at any age, depending on the cause. There is no indication that hereditary CDI causes are frequent. Central diabetes insipidus (CDI) is uncommon in neonates, particularly in very low-birth-weight newborns, and the great majority of cases are caused by disorders such as ischemia damage or bleeding brain injury. CDI is caused by a deficiency of antidiuretic hormone (ADH) as a result of posterior pituitary and/or hypothalamus dysfunction. We report a case of female, premature newborn, delivered in Sultan Qaboos Hospital in Salalah at 28 weeks gestational age, with a very low birth weight of 1001 grams. She also suffered polyuria and hypernatremia. The baby had hypernatremia and polyuria and low urine specific gravidity at the same time. Baby was early identified with central diabetes insipidus, we failed to control hypernatremia by fluid compensation but the case was effectively treated and controlled with oral desmopressin. Conclusion: Oral Desmopressin is effective and safe in the treatment of CDI but therapy necessitates frequent monitoring of hydration status, polyuria, serum sodium, and dosage calibration as needed.
No takes yet. Share an insight, caveat, or question.
Allam Abuhamda (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: